Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2008
05/01/2008US20080102471 Expression vector comprising nucleotide sequences coding myeblastosis (MYB) regulatory proein for use as tool in controlling heterologus gene expression in plants
05/01/2008US20080102463 Expression vector comprising nucleotide sequences coding glutamate peptidase for use in identifying modulators for prevention and treatment of schizophrenic brain disorders
05/01/2008US20080102458 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
05/01/2008US20080102448 Plasmid comprising two restriction recognition sequences different in nucleotide sequence for use as tool in heterologous gene expression; improving exogenous transcription vehicles
05/01/2008US20080102440 Pressure sensing apparatus comprising neuronal cells for use in analyzing underwater acoustics
05/01/2008US20080102438 Using spin induced sedimentation as tool to generate solid support with radially aligned pore structures for use in organ and tissue engineering; dialysis and phase separation membranes; water and liquid waste purification
05/01/2008US20080102115 Modified coagulation factor IX polypeptides and use thereof for treatment
05/01/2008US20080102083 Compositions and Methods for the Preparation of Human Growth Hormone Glycosylation Mutants
05/01/2008US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof
05/01/2008US20080102075 Enzymatic polypeptide which cleaves tumor necrosis factor receptor for use in treatment and prevention of arthritis and inflammatory disorders
05/01/2008US20080102072 Cytokine specific immunoglobulin for prevention and treatment of diabetes, autoimmune and inflammatory disorders
05/01/2008US20080102063 Inducing mesenchymal, adipose-derived or hematopoietic progenitor cells to differentiate into autoimmune T-cells for use in treatment of nervous system disorders
05/01/2008US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
05/01/2008US20080102059 Using growth factor-stem cell mixture as therapeutic in prevention of inflammation
05/01/2008US20080102057 Bipotential liver cell lines from wild-type mammalian liver tissue
05/01/2008US20080102054 Aorta gonad mesoderm composition for use in treatment of nervous system, blood, inflammatory, autoimmune, skin, respiratory and liver disorders
05/01/2008US20080102040 Inhibition of factor b, the alternative complement pathway and methods related thereto
05/01/2008US20080098585 Plate and method for high throughput screening
04/2008
04/30/2008EP1916307A1 Plant enzymes for bioconversion
04/30/2008EP1916303A1 Nucleic acids encoding rearranged human immunoglobulin sequences from transgenic transchromosomal mice
04/30/2008EP1916302A1 Method of producing lymphocytes
04/30/2008EP1916300A1 Chimeric animal and method for producing the same
04/30/2008EP1916299A1 Dna, vector, transformant and method for producing apa protein
04/30/2008EP1916298A1 Method for production of antibody
04/30/2008EP1916297A2 Cell separation compositions and methods
04/30/2008EP1916258A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
04/30/2008EP1916001A2 Human antibodies specific to KDR and uses thereof
04/30/2008EP1915904A1 Method of treating mouse carrying human hepatocytes
04/30/2008EP1915456A1 Cancerous disease modifying antibodies
04/30/2008EP1915455A1 Cancerous disease modifying antibodies
04/30/2008EP1915444A2 Methods to express recombinant proteins from lentiviral vectors
04/30/2008EP1915440A2 Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
04/30/2008EP1915398A2 Human anti-b7rp1 neutralizing antibodies
04/30/2008EP1915165A2 Topographical templating of polymeric materials using cellular morphology
04/30/2008EP1915161A2 Antisense antibacterial method and compound
04/30/2008EP1649000A4 Seeding pancreatic cells on porous matrices
04/30/2008EP1458240B1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
04/30/2008EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same
04/30/2008EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization
04/30/2008EP1127072B1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla
04/30/2008EP1034254B1 Uses of immortalized, homozygous stat1-deficient mammalian cell lines
04/30/2008EP0730657B1 Composition for the in vivo production of therapeutic products
04/30/2008DE112005002530T5 Neue Verfahren für die in-vitro Identifikation, Isolierung und Differenzierung von vaskulogenischen Vorläuferzellen New method for the in vitro identification, isolation and differentiation of vasculogenic progenitor cells
04/30/2008DE112004002408B4 Verfahren zur Gewinnung einer angereicherten Population von siRNA-exprimierenden Zellen A process for obtaining an enriched population of siRNA-expressing cells
04/30/2008CN101171516A Synthetic and standardised prion infectious material and uses thereof as an infecting inoculum
04/30/2008CN101171334A Methods of producing proteins having triple-helix structure
04/30/2008CN101168732A Method for producing Vinca rosea alkaloid
04/30/2008CN101168724A Cell electrofusion chip and processing method thereof
04/30/2008CN101167747A Bull semen diluent and its configuration method and adding method
04/30/2008CN101167745A Small molecular sugar stable buffer used for blood platelet frozen-dried preservation
04/30/2008CN101167441A Calamus simplicifolius clone tissue culture and fast propagation method
04/30/2008CN100385006C Method for secretory production of glycoprotein having human-type sugar chain using plant cell
04/30/2008CN100385005C Methods for the production of multimeric proteins, and related compositions
04/30/2008CN100385004C Cold shock inducible expression and production of heterologous polypeptides
04/30/2008CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins
04/30/2008CN100384995C Transformed silkworm producing human collagen
04/30/2008CN100384987C Method for expanding hemopoietic stem cell under three-dimensional condition
04/30/2008CN100384986C Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
04/30/2008CN100384878C Antibodies specific for human cd22 and their therapeutic anddiagnostic uses
04/30/2008CN100384877C Antibody ('11c7') anti nogo a and its pharmaceutical use
04/30/2008CN100384390C Complex tissue of tissue-engineered bone and cartilage and external constructing method thereof
04/29/2008US7365252 Plants and seeds of corn variety LH342
04/29/2008US7365251 Plants and seeds of corn variety I576433
04/29/2008US7365250 Plants and seeds of corn variety I291278
04/29/2008US7365249 Plants and seeds of corn variety I062687
04/29/2008US7365246 Soybean cultivar 435.TCS
04/29/2008US7365245 Soybean cultivar 495.RC
04/29/2008US7365244 Soybean cultivar 5348287
04/29/2008US7365243 Soybean cultivar 5204220
04/29/2008US7365242 Suppression of specific classes of soybean seed protein genes
04/29/2008US7365189 Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis
04/29/2008US7365186 for genetically engineered plants with increased lignin production using regulatory sequences isolated from Eucalyptus grandis capable of initiating and promoting the transcription of polynucleotides in plant cells undergoing xylogenesis
04/29/2008US7365184 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production
04/29/2008US7365180 Enzymes that bind to and/or depolymerize cellulose; food, beer, wine, animal feeds, textile production and laundering, pulp and paper industry, and agricultural industries
04/29/2008US7365177 Expression vector comprising nucleotide sequences which code chromogenic protein for use in transformation and generation of fish animal models of disease
04/29/2008US7365175 Wit 3.0, a novel gene to control soft tissue wound healing
04/29/2008US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents
04/29/2008US7365169 T-bet antibodies
04/29/2008US7365160 Membrane protein for use as diagnostic tool in detection and screening of xenobiotics; drug screening
04/29/2008US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as
04/29/2008US7365158 Antiproliferative agents; anticancer agents
04/29/2008US7365157 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological disorders
04/29/2008US7365052 Tendon-inducing methods
04/29/2008US7364903 Cell lines that stably or transiently express a functional umami (T1R1/T1R3) taste receptor
04/29/2008US7364902 Mobilization of viral genomes from T-DNA using site-specific recombination systems
04/29/2008US7364901 Recombinant Stokesia epoxygenase gene
04/29/2008US7364900 Contacting bone marrow stromal cells with neuronal and/or endodermal precursor tissue, transfecting diffferentiated endoderm/neuronal tissues with vector comprising therapeutic protein for use in treatment of cancer, diabetes, pancreatitis, liver and inflammatory bowel diseases
04/29/2008US7364878 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements
04/29/2008US7364867 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals
04/29/2008US7364866 Insecticides; generating immunology response
04/29/2008US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1)
04/29/2008US7364864 ANGE gene in atopy
04/29/2008US7364863 Monoclonal antibody for use in classification and identification of embryonic connective tissue progenitor cells; regenerative medicine
04/29/2008US7364852 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus
04/29/2008US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
04/29/2008US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies
04/29/2008US7364730 Human K+ channel and prognosing applications thereof
04/29/2008US7364725 Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor
04/29/2008US7364565 Controlled enzymatic removal and retrieval of cells
04/29/2008CA2370098C Human beta-trcp protein